EDAP TMS reported EUR6.82M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
AngioDynamics USD 38.86M 1.05M Feb/2025
Boston Scientific USD 3.68B 136M Dec/2025
EDAP TMS EUR 6.82M 1.13M Jun/2025
Henry Schein USD 1.06B 37M Dec/2025
Medtronic USD 5.41B 27M Dec/2025
Veracyte USD 101.97M 10.69M Dec/2025